SEC 13F Intelligence

Bridgecreek Investment Management, LLC / EW

Bridgecreek Investment Management, LLC’s Edwards Lifesciences Corp Position

Does Bridgecreek Investment Management, LLC own Edwards Lifesciences Corp (EW)? Not currently — the last reported position was 144.6K shares worth $19M in Q4 2021; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$19M
Q4 2021
Shares
144.6K
% of Portfolio
+2.56%
Quarters Held
13
position exited

Position History EW

Reported value by quarter
Q4 ’18: $8MQ4 ’18Q1 ’19: $10MQ2 ’19: $9MQ2 ’19Q3 ’19: $11MQ4 ’19: $12MQ4 ’19Q1 ’20: $10MQ2 ’20: $11MQ2 ’20Q3 ’20: $13MQ4 ’20: $15MQ4 ’20Q1 ’21: $13MQ2 ’21: $15MQ2 ’21Q3 ’21: $16MQ4 ’21: $19MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2021144.6K$19M+2.56%
Q3 2021144.7K$16M+2.34%
Q2 2021145.3K$15M+2.19%
Q1 2021159.3K$13M+2.06%
Q4 2020160.7K$15M+2.22%
Q3 2020159.3K$13M+2.23%
Q2 2020159.2K$11M+2.06%
Q1 202053.0K$10M+2.59%
Q4 201951.7K$12M+2.19%
Q3 201951.6K$11M+2.36%
Q2 201951.2K$9M+1.98%
Q1 201951.1K$10M+2.07%
Q4 201850.2K$8M+2.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridgecreek Investment Management, LLC’s full portfolio or all institutional holders of EW.